| Title: | Does the Common Type 2 Diabetes-Susceptibility Variant in the MTNR1B Gene Matter for Glycemic Control Among Patients on Antidiabetic Pharmacotherapy? |
| Journal: | Mayo Clinic Proceedings |
| Published: | 1 May 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33958070/ |
| DOI: | https://doi.org/10.1016/j.mayocp.2021.03.005 |
| URL: | http://www.mayoclinicproceedings.org/article/S0025619621001841/pdf |
| Citations: | 3 (1 in last 2 years) as of 8 Aug 2024 |
Publication 7470
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
16 Keywords
- Adult
- Aged
- Biomarkers
- Blood Glucose
- Diabetes Mellitus, Type 2
- Female
- Genetic Markers
- Genetic Predisposition to Disease
- Genotyping Techniques
- Humans
- Hypoglycemic Agents
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Receptor, Melatonin, MT2
- Treatment Outcome
2 Authors
- Xiao Tan
- Christian Benedict
1 Application
| Application ID | Title |
|---|---|
| 43015 | Melatonin, lifestyle, and health: a gene-environmental investigation in the UK Biobank |
Enabling scientific discoveries that improve human health